AMYT logo

Amryt Pharma (AMYT) Cash From Operations

Annual CFO

$15.54 M
-$11.35 M-42.21%

December 31, 2021


Summary


Performance

AMYT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAMYTcash flowmetrics:

Quarterly CFO

$14.34 M
+$20.29 M+340.67%

September 30, 2022


Summary


Performance

AMYT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAMYTcash flowmetrics:

TTM CFO

$108.27 M
+$138.67 M+456.23%

September 30, 2022


Summary


Performance

AMYT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAMYTcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AMYT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-42.2%+111.5%+225.7%
3 y3 years+200.6%+224.0%+388.9%
5 y5 years+209.2%-+388.9%

AMYT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-86.7%-152.6%at high-128.1%
5 y5-year-42.2%-341.1%-86.7%-967.2%at high-179.5%
alltimeall time-42.2%-341.1%-86.7%-967.2%at high-179.5%

Amryt Pharma Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2022
-
$14.34 M(-340.7%)
$108.27 M(-456.2%)
Jun 2022
-
-$5.96 M(-21.0%)
-$30.39 M(-677.9%)
Mar 2022
-
-$7.54 M(-107.0%)
$5.26 M(-66.2%)
Dec 2021
$15.54 M(-42.2%)
$107.43 M(-186.4%)
$15.54 M(-118.0%)
Sep 2021
-
-$124.33 M(-518.7%)
-$86.12 M(-273.4%)
Jun 2021
-
$29.70 M(+983.8%)
$49.65 M(+111.8%)
Mar 2021
-
$2.74 M(-52.6%)
$23.44 M(-12.8%)
Dec 2020
$26.89 M(-171.8%)
$5.78 M(-49.5%)
$26.89 M(+358.7%)
Sep 2020
-
$11.44 M(+228.0%)
$5.86 M(-134.2%)
Jun 2020
-
$3.49 M(-43.6%)
-$17.14 M(-33.7%)
Mar 2020
-
$6.19 M(-140.6%)
-$25.84 M(-31.0%)
Dec 2019
-$37.47 M
-$15.25 M(+31.9%)
-$37.47 M(+68.6%)
Sep 2019
-
-$11.56 M(+121.5%)
-$22.22 M(+108.5%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$5.22 M(-4.1%)
-$10.66 M(+95.9%)
Mar 2019
-
-$5.44 M
-$5.44 M
Dec 2018
-$15.45 M(+8.6%)
-
-
Dec 2017
-$14.23 M(+121.4%)
-
-
Dec 2016
-$6.43 M(+300.2%)
-
-
Dec 2015
-$1.61 M(-56.8%)
-
-
Mar 2015
-$3.72 M(+79.8%)
-
-
Mar 2014
-$2.07 M(+92.0%)
-
-
Mar 2013
-$1.08 M(+460.6%)
-
-
Mar 2012
-$192.10 K(-32.8%)
-
-
Mar 2011
-$286.00 K(+11.6%)
-
-
Mar 2010
-$256.20 K(-76.3%)
-
-
Dec 2007
-$1.08 M
-
-

FAQ

  • What is Amryt Pharma annual cash flow from operations?
  • What is the all time high annual CFO for Amryt Pharma?
  • What is Amryt Pharma annual CFO year-on-year change?
  • What is Amryt Pharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Amryt Pharma?
  • What is Amryt Pharma quarterly CFO year-on-year change?
  • What is Amryt Pharma TTM cash flow from operations?
  • What is the all time high TTM CFO for Amryt Pharma?
  • What is Amryt Pharma TTM CFO year-on-year change?

What is Amryt Pharma annual cash flow from operations?

The current annual CFO of AMYT is $15.54 M

What is the all time high annual CFO for Amryt Pharma?

Amryt Pharma all-time high annual cash flow from operations is $26.89 M

What is Amryt Pharma annual CFO year-on-year change?

Over the past year, AMYT annual cash flow from operations has changed by -$11.35 M (-42.21%)

What is Amryt Pharma quarterly cash flow from operations?

The current quarterly CFO of AMYT is $14.34 M

What is the all time high quarterly CFO for Amryt Pharma?

Amryt Pharma all-time high quarterly cash flow from operations is $107.43 M

What is Amryt Pharma quarterly CFO year-on-year change?

Over the past year, AMYT quarterly cash flow from operations has changed by +$138.67 M (+111.53%)

What is Amryt Pharma TTM cash flow from operations?

The current TTM CFO of AMYT is $108.27 M

What is the all time high TTM CFO for Amryt Pharma?

Amryt Pharma all-time high TTM cash flow from operations is $108.27 M

What is Amryt Pharma TTM CFO year-on-year change?

Over the past year, AMYT TTM cash flow from operations has changed by +$194.39 M (+225.73%)